FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Complicated Urinary Tract Infection
• Dental Infection
• Exacerbation of Chronic Bronchitis
• Intra-abdominal Infection
• Otitis Media
• Skin and Skin Structure Infections

Drugs mentioned

• AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

SUPPL AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)